« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6
, Pages 1632-1636.e2
, June 2010
Infection after implantation of pulsatile mechanical circulatory support devices
References
- INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065–1072
- . Artificial Heart and Assist Devices: Directions, needs, costs, societal and ethical issues. Bethesda: National Institutes of Health; 1985;
- Novacor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg. 2000 Mar;119:581–587
- . Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003;237:631–637
- Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186–1195
- The REMATCH trial: rationale, design, and end points. Ann Thorac Surg. 1999;67:723–730
- Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103:231–237
- Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080–1090
- . Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation. 2003;(Suppl):108;II272-7
- . Improved outcomes with an implantable left ventricular assist system: a multicenter study. Ann Thorac Surg. 2001;71:205–209
- Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505
- Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11:133–138
- Use of an intraperitoneal ventricular assist device with a polytetrafluoroethylene barrier decreases infection. J Heart Lung Transplant. 2008;27:268–271
- Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg. 2003;75(suppl):S48–S57
- Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
- Infection in permanent circulatory support: experience from the REMATCH Trial. J Heart Lung Transplant. 2003;23:1359–1365
- Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44–50
- Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26:219–229
- Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896
- First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant. 2005;24:1188–1194
- . Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 heart in patients with previous median sternotomy. J Heart Lung Transplant. 2006;25:499–503
- . The Jarvik 2000 Oxford system: increasing the scope of mechanical circulatory support. J Thorac Cardiovasc Surg. 1997;114:467–474
Disclosures: Margarita T. Camacho reports fees and grant support from Thoratec.
PII: S0022-5223(10)00046-2
doi: 10.1016/j.jtcvs.2010.01.014
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6
, Pages 1632-1636.e2
, June 2010
